semaglutide uses Summary of clinical use Semaglutide Injections: Benefits, Side Effects,

pharmaceutical company Pfizer is developing a GLP-1 drug administered as a once-monthly injection

J Neuroendocrinol 24(12):15051516 Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR et al (2019) Glucagon-like peptide 1 (GLP-1)

Another acceptable injection site is the upper arm (specifically the back of the arm), as it also provides enough fatty tissue for proper absorption

These warning signs should trigger immediate caution

One hour of exercise per day is often enough to prevent people from regaining weight

Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026